Please login to the form below
Purdue Pharma appoints Dr Craig Landau as its CEO
He also takes up president role
Purdue Pharma has appointed Dr Craig Landau as its new chief executive officer and president, roles that will see him be responsible for the firm’s US operations and retain responsibility for Purdue’s Canadian operations.
Landau first joined the Connecticut, US-based firm as president and CEO of Purdue Pharma Canada, he's spent the last three years diversifying and stabilising the business through a number of strategic business development deals.
He said: "I am honoured to be leading these organisations at such an exciting time.
"I look forward to building on Purdue’s rich history and working with my talented colleagues as we continue to broaden our portfolio and innovate to support healthcare professionals and serve patient needs.”
He succeeds Mark Timey who leaves Purdue Pharma to “pursue other career opportunities”.
Featured jobs
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
- FREELANCE Medical Writer (Initial 2/ 3 months term) - London Off...
-
Excellent Daily Rate
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
- Account Director, Healthcare Communications
-
Salary TBC
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Account Director - Medical Communications - London / South East
-
Excellent Salary and Benefits on offer
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
-
Account Director – UK Office
-
Excellent salary and benefits
Subscribe to our email news alerts
- GSK hires Merck KGaA exec to lead US pharma business
- Novartis chooses internal replacement for US pharma president role
- Moving annual total (MAT)
- Roche undercuts price of Bayer cancer drug after winning FDA approval
- Novartis chooses internal replacement for US pharma president role
- Lilly psoriasis drug beats J&J's Tremfya in head-to-head trial
- A uniquely English genomic medicine service
- FDA rejects Sarepta’s new Duchenne drug over safety fears
- AZ claims first-in-class win for Farxiga in heart failure
- UK no longer measles-free as vaccination rates fall dramatically
- Lilly’s Levi Garraway will replace Sandra Horning as Roche CMO
- Blended Intelligence
PMHub
Wilmington Healthcare
A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...
Latest intelligence
- A uniquely English genomic medicine service
- The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
- Blended Intelligence
- Data is the most valued commodity of the modern world. For P&P it's all about the application....
- The relevance of patient perspectives to value
- Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
Quick links
Infographics
